CD8A and neoplasm: Moreover, given the pre-treatment TMEstates with reduced CD8+ TIL density in cold tumours orthose exhibiting T cell exclusion, it is necessary to evaluate whether STINGagonist treatment could reverse these to a T cell inflamed state.